382 related articles for article (PubMed ID: 9268496)
21. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
[TBL] [Abstract][Full Text] [Related]
22. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Wu HY; Monsonego A; Weiner HL
J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
[TBL] [Abstract][Full Text] [Related]
23. Major histocompatibility complex controls clonal proliferation of CD5+ B cells in H-2-congenic New Zealand mice: a model for B cell chronic lymphocytic leukemia and autoimmune disease.
Okada T; Takiura F; Tokushige K; Nozawa S; Kiyosawa T; Nakauchi H; Hirose S; Shirai T
Eur J Immunol; 1991 Nov; 21(11):2743-8. PubMed ID: 1718758
[TBL] [Abstract][Full Text] [Related]
24. T cell-independent and T cell-dependent B cell activation increases IFN-gamma R expression and renders B cells sensitive to IFN-gamma-mediated inhibition.
Abed NS; Chace JH; Cowdery JS
J Immunol; 1994 Oct; 153(8):3369-77. PubMed ID: 7523492
[TBL] [Abstract][Full Text] [Related]
25. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
Youinou P; Pers JO; Jamin C; Lydyard PM
Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
[TBL] [Abstract][Full Text] [Related]
27. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
[TBL] [Abstract][Full Text] [Related]
28. Differences between normal and autoimmune T cell responses to autologous erythrocytes and haemoglobin: impairment of haptoglobin-mediated inhibition in NZB spleen cells.
Calkins CE; Esposito M
J Autoimmun; 1996 Aug; 9(4):453-62. PubMed ID: 8864820
[TBL] [Abstract][Full Text] [Related]
29. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus.
Rozzo SJ; Drake CG; Chiang BL; Gershwin ME; Kotzin BL
J Immunol; 1994 Aug; 153(3):1340-51. PubMed ID: 7913114
[TBL] [Abstract][Full Text] [Related]
30. Cell cycle analysis of lymphocyte activation in normal and autoimmune strains of mice.
Raveche ES; Steinberg AD; DeFranco AL; Tjio JH
J Immunol; 1982 Sep; 129(3):1219-26. PubMed ID: 6125541
[TBL] [Abstract][Full Text] [Related]
31. The immature B-cell subpopulation with low RAG1 expression is increased in the autoimmune New Zealand Black mouse.
Toda T; Kitabatake M; Igarashi H; Sakaguchi N
Eur J Immunol; 2009 Feb; 39(2):600-11. PubMed ID: 19180472
[TBL] [Abstract][Full Text] [Related]
32. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
33. Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1.
Kim PH; Eckmann L; Lee WJ; Han W; Kagnoff MF
J Immunol; 1998 Feb; 160(3):1198-203. PubMed ID: 9570534
[TBL] [Abstract][Full Text] [Related]
34. Macrophages and abnormal BCL-6 or c-MYC gene expression affect the resistance of peritoneal B cells to induction of hyporesponsiveness.
Liou LB; Wu MW; Chao WJ
Scand J Immunol; 2009 May; 69(5):447-56. PubMed ID: 19508376
[TBL] [Abstract][Full Text] [Related]
35. Immune mechanisms leading to abnormal B cell selection and activation in New Zealand Black mice.
Roy V; Bonventi G; Cai Y; Macleod R; Wither JE
Eur J Immunol; 2007 Sep; 37(9):2645-56. PubMed ID: 17668901
[TBL] [Abstract][Full Text] [Related]
36. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
37. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
38. An intrinsic B-cell defect supports autoimmunity in New Zealand black chromosome 13 congenic mice.
Loh C; Pau E; Chang NH; Wither JE
Eur J Immunol; 2011 Feb; 41(2):527-36. PubMed ID: 21268021
[TBL] [Abstract][Full Text] [Related]
39. Defective B cell tolerance induction in New Zealand black mice. I. Macrophage independence and comparison with other autoimmune strains.
Goldings EA
J Immunol; 1983 Dec; 131(6):2630-4. PubMed ID: 6196392
[TBL] [Abstract][Full Text] [Related]
40. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
